Cargando…

Targeting Innate Immunity in Cancer Therapy

The majority of current cancer immunotherapy strategies target and potentiate antitumor adaptive immune responses. Unfortunately, the efficacy of these treatments has been limited to a fraction of patients within a subset of tumor types, with an aggregate response rate of approximately 20% to date a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rameshbabu, Srikrishnan, Labadie, Brian W., Argulian, Anna, Patnaik, Akash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916062/ https://www.ncbi.nlm.nih.gov/pubmed/33572196 http://dx.doi.org/10.3390/vaccines9020138

Ejemplares similares

Suppression of tumor cell lactate-generating signaling pathways eradicates murine PTEN/p53-deficient aggressive-variant prostate cancer via macrophage phagocytosis
por: Chaudagar, Kiranj, et al.
Publicado: (2023)

Innate Immunity to Mucosal Candida Infections
por: Verma, Akash, et al.
Publicado: (2017)

Innate Immunity in Cancer Biology and Therapy
por: Zhang, Yuxia, et al.
Publicado: (2023)

Manipulation of Innate Immunity for Cancer Therapy in Dogs
por: Regan, Daniel, et al.
Publicado: (2015)

Innate Immune System in the Context of Radiation Therapy for Cancer
por: Boopathi, Ettickan, et al.
Publicado: (2023)

Innate Immunity and Biomaterials at the Nexus: Friends or Foes
por: Christo, Susan N., et al.
Publicado: (2015)

Guidelines for Management of Treatment-Emergent Adverse Events During Rucaparib Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer
por: Labadie, Brian W, et al.
Publicado: (2022)

Neutrophils and anti-cancer immunity: a paradigm shift in cancer immunotherapy
por: Sturey, Rebecca, et al.
Publicado: (2017)

The role of innate immunity in mucopolysaccharide diseases
por: Parker, Helen, et al.
Publicado: (2018)

The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease
por: Holleran, Grainne, et al.
Publicado: (2017)

The Ovarian Cancer Tumor Immune Microenvironment (TIME) as Target for Therapy: A Focus on Innate Immunity Cells as Therapeutic Effectors
por: Baci, Denisa, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors for Genitourinary Cancers: Treatment Indications, Investigational Approaches and Biomarkers
por: Labadie, Brian W., et al.
Publicado: (2021)

Targeting the CD47-SIRPα Innate Immune Checkpoint to Potentiate Antibody Therapy in Cancer by Neutrophils
por: Behrens, Leonie M., et al.
Publicado: (2022)

Targeting Innate Immunity to Treat Cancer
por: Austin, Matthew, et al.
Publicado: (2020)

Influence of Innate Immunity on Cancer Cell Stemness
por: Pastò, Anna, et al.
Publicado: (2020)

Innate Immunity in Mucopolysaccharide Diseases
por: Mandolfo, Oriana, et al.
Publicado: (2022)

Targeting Innate Immunity in Breast Cancer Therapy: A Narrative Review
por: Ye, Yanqi, et al.
Publicado: (2021)

The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy
por: Law, Andrew M K, et al.
Publicado: (2017)

Innate Immune Response in Kidney Ischemia/Reperfusion Injury: Potential Target for Therapy
por: Kezić, Aleksandra, et al.
Publicado: (2017)

Targeting Innate Immunity to Enhance the Efficacy of Radiation Therapy
por: Dar, Tahir B., et al.
Publicado: (2019)

The Innate Immune Microenvironment in Metastatic Breast Cancer
por: Tommasi, Chiara, et al.
Publicado: (2022)

Killers at the crossroads: The use of innate immune cells in adoptive cellular therapy of cancer
por: Sabry, May, et al.
Publicado: (2020)

Nanoparticles Targeting Innate Immune Cells in Tumor Microenvironment
por: Jang, Hochung, et al.
Publicado: (2021)

Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer
por: Zeller, Tobias, et al.
Publicado: (2023)

Why Target Innate Immune Cells in Cancers?
por: Poupot, Mary
Publicado: (2021)

Metabolism of Innate Immune Cells in Cancer
por: Talty, Ronan, et al.
Publicado: (2021)

Autophagy, the innate immune response and cancer
por: Gerada, Chelsea, et al.
Publicado: (2020)

Exploiting innate immunity for cancer immunotherapy
por: Yi, Ming, et al.
Publicado: (2023)

The Challenge for Gene Therapy: Innate Immune Response to Adenoviruses
por: Thaci, Bart, et al.
Publicado: (2011)

Innate Immunity and Biological Therapies for the Treatment of Sjögren’s Syndrome
por: Srivastava, Amrita, et al.
Publicado: (2020)

Innate Immune Response to Viral Vectors in Gene Therapy
por: Wang, Yixuan, et al.
Publicado: (2023)

Effectiveness of dialectical behavior therapy as a transdiagnostic treatment for improving cognitive functions: a systematic review
por: Vijayapriya, CV, et al.
Publicado: (2023)

Innate Immunity in Cardiovascular Diseases—Identification of Novel Molecular Players and Targets
por: Poller, Wolfgang, et al.
Publicado: (2023)

Neuroinflammation in retinitis pigmentosa: Therapies targeting the innate immune system
por: Zhao, Ling, et al.
Publicado: (2022)

Editorial: Innate immune cell therapy of cancer
por: Khatwani, Natasha, et al.
Publicado: (2022)

Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetes
por: Itoh, Arata, et al.
Publicado: (2017)

Bridging Innate and Adaptive Antitumor Immunity Targeting Glycans
por: Pashov, Anastas, et al.
Publicado: (2010)

Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways
por: Li, Kai, et al.
Publicado: (2017)

Clinical and molecular features of innate and acquired resistance to anti-PD-1/PD-L1 therapy in lung cancer
por: Shah, Shalin, et al.
Publicado: (2017)

Current Status of Immune Deficiency Pathway in Tenebrio molitor Innate Immunity
por: Jang, Ho Am, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4hp83k9seh0v1vtisljlliqd02